State KS
Clinical Trials in Kansas
Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 141 actively recruiting studies with Kansas sites out of 141 registered in total. The busiest research areas in Kansas are Breast Cancer, Cystic Fibrosis, Prostate Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Kansas Medical Center, AstraZeneca. By stage, Kansas trials break down as Phase 1 (22), Phase 2 (34), Phase 3 (46), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kansas
Frequently Asked Questions — Clinical Trials in Kansas
How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 141 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 141. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Cystic Fibrosis, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kansas
NCT06224660 Phase 1
Recruiting
Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Se...
Condition
DMD-Associated Dilated Cardiomyopathy
Enrollment
12 pts
Location
United States
Sponsor
Sardocor Corp.
NCT06660355 Phase 2
Recruiting
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Thera...
Condition
Chronic Graft-versus-host Disease (cGVHD)
Enrollment
120 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
NCT06668259 N/A
Recruiting
Intensive Longitudinal Assessment of Stress and Stress-related Concepts Across a...
Condition
Individual Stress and Weight Loss
Enrollment
50 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT07293260 Phase 3
Recruiting
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronar...
Condition
Cardiovascular Disease
Enrollment
406 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT07419425 Phase 4
Recruiting
My Path to Quit Tobacco
Condition
Smoking Cessation
Enrollment
1,550 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT06039176 N/A
Recruiting
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Condition
LVAD
Enrollment
150 pts
Location
United States
Sponsor
International Consortium of Ci
NCT06121297 Phase 1, Phase 2
Recruiting
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of C...
Condition
Systemic Lupus Erythematosus
Enrollment
28 pts
Location
United States, Canada, Spain
Sponsor
Cabaletta Bio
NCT06626113 N/A
Recruiting
Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertensio...
Condition
Obesity
Enrollment
60 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT03767595 N/A
Recruiting
ProACT Post-Approval Study
Condition
Stress Urinary Incontinence
Enrollment
145 pts
Location
United States
Sponsor
Uromedica
NCT04251052 N/A
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations t...
Condition
Ovarian Carcinoma
Enrollment
1,956 pts
Location
United States, Canada, South Korea
Sponsor
NRG Oncology
NCT06545955 Phase 3
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combinatio...
Condition
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Enrollment
250 pts
Location
United States, Canada, Czechia
Sponsor
Ferring Pharmaceuticals
NCT05517655 Phase 4
Recruiting
BEGIN Novel ImagiNG Biomarkers
Condition
Cystic Fibrosis
Enrollment
44 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT06958536 Phase 2
Recruiting
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's...
Condition
Crohn's Disease
Enrollment
99 pts
Location
United States, Australia, Belgium
Sponsor
Sanofi
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT05685433 N/A
Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Eval...
Condition
Overactive Bladder
Enrollment
200 pts
Location
United States
Sponsor
Valencia Technologies Corporat
NCT06932263 Phase 2
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults ...
Condition
Asthma
Enrollment
540 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT06236438 Phase 2, Phase 3
Recruiting
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, ...
Condition
Non-Small Cell Lung Cancer
Enrollment
840 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT07589595 Phase 2
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (T...
Condition
Cognitive Dysfunction
Enrollment
350 pts
Location
United States, Japan, South Korea
Sponsor
Eli Lilly and Company
NCT06632977 Phase 2
Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
474 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT07626281 Phase 1
Recruiting
Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a N...
Condition
Inclisiran Formulation
Enrollment
120 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
NCT05172245 Phase 1
Recruiting
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
46 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT06855277 Phase 3
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With P...
Condition
Prostate Cancer
Enrollment
940 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
NCT07206225 Phase 1
Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Can...
Condition
Non-muscle Invasive Bladder Cancer
Enrollment
294 pts
Location
United States, France, Israel
Sponsor
Pfizer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology